Horn Howard 4
4 · Ultragenyx Pharmaceutical Inc. · Filed Oct 14, 2025
Insider Transaction Report
Form 4
Horn Howard
Chief Financial Officer
Transactions
- Sale
Common Stock
2025-10-13$31.51/sh−7,942$250,252→ 98,227 total
Footnotes (2)
- [F1]Represents shares sold to pay required tax withholdings due to the vesting of RSUs.
- [F2]Includes previously reported shares of common stock underlying RSUs granted to the Reporting Person, which are subject to certain vesting conditions.